Search

everythinglearnresearchcommunity

for

Search:↓

Combining medication for dyslipidemia and insulin resistance with basic therapy improves outcomes for alopecia areata with metabolic syndrome.

Steroid sulfatase inhibitors could potentially treat hormone-related disorders like certain cancers, hair loss, acne, and improve cognitive dysfunction.

Women with androgenetic alopecia have fewer terminal hairs, phenol in nail surgery is safe, and a new hair transplant method is faster and less damaging.

Younger patients with severe alopecia areata often have nail problems.

Dysregulated lipid metabolism may play a role in male pattern baldness.

Some men lost hair after deoxycholic acid treatment for neck fat, but most saw improvement or resolution.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

A woman with type 2 diabetes developed alopecia areata, suggesting a link between the two autoimmune conditions.

There is no significant link between metabolic syndrome and alopecia areata.

Using patients' own fat-derived cells to treat alopecia areata significantly improved hair growth and was safe.

Two people had unusual ring-shaped hair loss due to an autoimmune disorder.

Alopecia areata causes hair loss with varied treatment responses and frequent relapses.

Surgery resolved the man's skin and liver issues, and he stayed symptom-free for a year.

Tetrathelmis tetrathele extract may help prevent hair loss and improve scalp health.

Hair regrowth improved, but quality of life did not.

Biorregulatory therapy significantly improved the dog's health, reversing previous issues and eliminating the need for ongoing medication.

Alopecia areata is a common autoimmune condition causing varying hair loss, diagnosed by specific patterns of inflammation around hair follicles, with several treatment options available.

Budesonide and N-acetylcysteine reduced tumors and alopecia in mice, regardless of FHIT gene status.

Certain gene variations may increase the risk of alopecia, and platelet-rich plasma treatment can improve hair density in those with hair loss; a rare case of facial Becker's nevus was linked to uneven beard growth.

PDLLA scalp injections improved hair regrowth in most patients with non-scarring alopecia.

Specific RNA patterns are linked to alopecia areata.

Cirrhosis affects quality of life with various symptoms, requiring a holistic, multidisciplinary approach for management.

EETs can delay seizures by affecting GABA activity, offering potential new treatments for seizures.

Peginterferon alpha-2a effectively treats acute hepatitis C in hemodialysed patients, despite some side effects.

EtG levels in hair decrease significantly after one month of alcohol abstinence.

The study concluded that patients with total hair loss and recurring hair loss had an earlier onset, longer-lasting condition, and a greater negative impact on their quality of life, with allergic conditions linked to more severe hair loss.

Long-term alcohol exposure alters brain receptor function differently in various brain regions.

5-aminolevulinic acid therapy reduces acne by decreasing fat production in skin cells.

HTLV-1-associated lichenoid dermatitis (HALD) is linked to an immune response against HTLV-1-infected cells.